Article Details

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and ...

Retrieved on: 2018-01-08 02:00:00

Tags for this article:

Click the tags to see associated articles and topics

Vaccinex, Inc. Announces Research Collaboration Employing ActivMAb® Platform Technology and .... View article details on hiswai:

Excerpt

<div>Headquartered in Cambridge, Mass., Surface was founded by <b>Atlas Venture</b> and is also supported by leading biotechnology venture investors F-Prime Capital Partners, Lilly Ventures, New Enterprise Associates (NEA) and Amgen Ventures. For more information, please visit www.surfaceoncology.com.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo